Altimmune, Inc.

BrandBiotechnology ResearchGaithersburg, MarylandWebsite

Company Overview

Altimmune is a late clinical-stage biopharmaceutical company developing therapies to improve the lives of people living with serious liver diseases.Our lead program is a differentiated dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio, currently in development for metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD) and alcohol-associated liver disease (ALD).#ClinicalResearch #LiverCare #BioResearch

Founded

1997

Headquarters

Gaithersburg, Maryland

Employees

11-50

3.8% last 12mo

Marketing Team

3

4% of company

Overall Headcount Trend

Overall Headcount Trend

Company growth over the last 12 months

Salaries

Community Salary Data

Help build salary transparency at Altimmune, Inc.. Share your compensation anonymously.

Reviews

Rate This Company

Share your experience working here including compensation, culture, and work-life balance.

News

Altimmune Stock: Probing Pemvi's MASH Data (NASDAQ:ALT)

Nov 14, 2025 • Seeking Alpha

Altimmune, Inc. Reports Positive 24-Week Efficacy Results from IMPACT Phase 2b Trial of Pemvidutide in Treating Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Nov 11, 2025 • Quiver Quantitative

Altimmune releases additional phase 2 pemvidutide data for MASH

Nov 11, 2025 • Seeking Alpha

Jobs

5 days ago

Director, Communications

Altimmune, Inc. / In-house

Gaithersburg, MD Remote Full-time Director/Executive8+ years exp

5 days ago

Director, Communications

Altimmune, Inc. / In-house

Gaithersburg, MD Remote Full-time Director/Executive8+ years exp